ProGenTech partners with China CDC

ProGenTech, a life science and molecular diagnostics company based in Shanghai, China, and the San Francisco Bay area, USA, has signed a  collaboration agreement with the China Centers for Disease Control and  Preention (CDC) to create a joint laboratory that will focus on  developing next-generation molecular diagnostic systems and assays.

Under the terms of the deal, the joint laboratory will leverage  ProGenTech's existing Entura instrument platform and proprietary  cassettes for the development of an integrated molecular diagnostic  system. This joint system will be specifically designed for the rapid  surveillance and detection of existing and emerging pathogens  identified by the CDC in China. Development of ProGenTech's first  fully-automated systems for sample preparation was driven by an emphasis  on affordability and usability, design concepts the company plans to  carry forward into this joint effort, the firms say.

Commenting on this new relationship, XiaoYong Tong of China CDC said:  "this collaboration provides the latest molecular diagnostic technology  to enhance China CDC's ability in the area of infectious disease  detection and prevention."